Disease-related protein variants of the highly conserved enzyme PAPSS2 show marginal stability and aggregation in cells

  • Cellular sulfation pathways rely on the activated sulfate 3'-phosphoadenosine-5'-phosphosulfate (PAPS). In humans, PAPS is exclusively provided by the two PAPS synthases PAPSS1 and PAPSS2. Mutations found in the PAPSS2 gene result in severe disease states such as bone dysplasia, androgen excess and polycystic ovary syndrome. The APS kinase domain of PAPSS2 catalyzes the rate-limiting step in PAPS biosynthesis. In this study, we show that clinically described disease mutations located in the naturally fragile APS kinase domain are associated either with its destabilization and aggregation or its deactivation. Our findings provide novel insights into possible molecular mechanisms that could give rise to disease phenotypes associated with sulfation pathway genes.

Download full text files

Export metadata

Additional Services

Share in Twitter Search Google Scholar
Metadaten
Author:Oliver BrylskiGND, Puja ShresthaGND, Philip J. HouseGND, Patricia GnuttGND, Jonathan Wolf MüllerGND, Simon EbbinghausORCiDGND
URN:urn:nbn:de:hbz:294-91540
DOI:https://doi.org/10.3389/fmolb.2022.860387
Parent Title (English):Frontiers in molecular biosciences
Publisher:Frontiers
Place of publication:Lausanne
Document Type:Article
Language:English
Date of Publication (online):2022/07/26
Date of first Publication:2022/04/08
Publishing Institution:Ruhr-Universität Bochum, Universitätsbibliothek
Tag:PAPS synthase; in-cell spectroscopy; protein folding; stability and aggregation; sulfation pathways
Volume:9
Issue:Article 860387
First Page:860387-1
Last Page:860387-8
Institutes/Facilities:Lehrstuhl für Physikalische Chemie II
Dewey Decimal Classification:Naturwissenschaften und Mathematik / Chemie, Kristallographie, Mineralogie
open_access (DINI-Set):open_access
faculties:Fakultät für Chemie und Biochemie
Licence (English):License LogoCreative Commons - CC BY 4.0 - Attribution 4.0 International